Background Data about the long-term mortality of acute myocardial infarction (AMI) patients with renal insufficiency who received sufficient early revascularization are scant, so the present study evaluated the impact of serum creatinine levels on the long-term mortality in patients with AMI undergoing successful primary percutaneous coronary intervention (PCI).
revious studies showed that patients with renal insufficiency were at increased risk for both cardiovascular disease and adverse cardiovascular outcomes. 1, 2 In particular, patients on dialysis who have an acute myocardial infarction (AMI) are thought to have high mortality from cardiac causes and poor long-term survival. [3] [4] [5] Moreover, renal insufficiency, measured as corrected creatinine clearance, blood urea nitrogen or serum creatinine level, has also been investigated in multiple epidemiological studies and clinical trials and found to be an independent predictor of survival in patients with acute coronary syndrome or AMI. 6, 7 Several investigators suggested that patients with renal insufficiency were at an increased risk for cardiovascular mortality, because established, aggressive modern reperfusion and adjunctive medical therapies were not used frequently. 8, 9 Prompt restoration of antegrade flow in the infarct-related coronary artery is the primary objective of treatment strategies in patients with AMI, [10] [11] [12] but there are few studies examining the long-term mortality of AMI patients with renal insufficiency who underwent successful primary percutaneous coronary intervention (PCI), because major cardiovascular disease trials frequently exclude patients with renal dysfunction. 13 A recent report of a sub-analysis of the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial 14 showed that renal insufficiency in patients undergoing primary angioplasty for AMI was an independent predictor of mortality; because of its exclusion criteria the study population of that trial did not include all renal insufficiency patients.
The Heart Institute of Japan Acute Myocardial Infarction , and stents were implanted in 76.5% (1,040 patients) of all patients who underwent primary PCI. Because the HIJAMI registry was for observational purposes only, treatment strategies, such as early reperfusion treatment and medication, were left to the discretion of the responsible physician at each hospital. Overall inhospital mortality was 9.7%, compared with 6.4% for patients with successful PCI. The main cause of in-hospital death was cardiogenic shock (3.3%). Using this observational cohort, the present study examined the impact of the serum creatinine concentration on the long-term mortality of those patients who underwent successful primary PCI.
Methods

Study Population
From the HIJAMI registry we examined 1,359 consecutive patients with AMI who underwent successful primary PCI. Serum creatinine concentration was measured on admission in all patients. The blood was withdrawn in the emergency room or coronary care unit before emergency coronary angiography. The patients were initially classified into 2 groups based on serum creatinine. The median baseline creatinine of our study population was 0.9 mg/dl (interquartile range 0.7-1.1), so the normal serum creatinine group was defined as <1.2 mg/dl and the elevated serum creatinine group was ≥1.2 mg/dl. The 2 strata of serum creatinine level were examined before detailed analyses were done to ensure that there was a reasonable number of patients in each stratum to perform multivariate analysis and to ensure the cut-off points were clinically meaningful. Clinical information at the time of presentation and data obtained at the time of procedure and at discharge were recorded prospectively on standard case report forms and sent to a central data collection center (STATZ Institute, Inc, Tokyo, Japan).
Follow-up Data
Clinical follow-up data were obtained from outpatient records or by a trained clinical research secretary of each hospital who made telephone contact with patients on a yearly basis. Patients were questioned, using a standard format, about the recurrence of cardiac symptoms and the need for hospitalization related to heart disease. Family members of deceased patients were contacted to ascertain time of death. The primary endpoint of the present study was all-cause death at follow-up. Univariate and multivariate hazard ratios (HR) were calculated for renal risk using the baseline serum creatinine level. Written informed consent was given by each patient prior to enrolment. The ethics committee of each participating hospital approved the study.
Definitions
AMI was defined when 2 or more of the following conditions were satisfied: (1) typical chest pain, (2) an increase in creatine kinase to twice the normal level or greater, and (3) persistent elevation/decrease in the ST segment or a change in T waves in 2 or more contiguous leads or development of a new abnormal Q wave or left bundle branch block on ECG. Primary PCI was defined as percutaneous coronary revascularization within 24 h of the onset of AMI without the use of intravenous/intracoronary fibrinolytic agents as an initial therapy to restore coronary blood flow. The type of revascularization procedure, including usage of stents, was left to the discretion of the doctor. All patients received aspirin (81 or 100 mg) in advance of the procedure and aspirin administration continued indefinitely afterward to avoid any complications. Patients who underwent stenting were also treated with 100 mg of ticlopidine twice daily for at least 4 weeks to avoid any complication. Heparin was administered during the procedure to maintain an activated clotting time of 250-300 s. Treatment with glycoprotein IIb/IIIa receptor inhibitor was not performed because it is not available in Japan. Reperfusion success was defined as Thrombolysis In Myocardial Infarction grade 3 flow 16 and residual stenosis less than 50%.
Statistical Analysis
Analyses were performed with the SAS system version 9.1 (SAS Institute Inc, Cary, NC, USA). Data are presented as mean ± SD, medians with interquartile ranges or frequencies. The normality of the continuous variables was evaluated by Shapiro-Wilks test. Student's t-test was used to compare groups with respect to normally distributed continuous variables, and the Mann-Whitney U-test was used for other variables. The chi-square test was used to compare nominally scaled variables. The cumulative probabilities of the event-free curves were estimated with the Kaplan-Meier method. To evaluate the effects of serum creatinine, multivariable Cox proportional hazards model was used. The variables entered into the model were age, gender, systemic hypertension, diabetes, hyperlipidemia, previous myocardial infarction (MI), the number of narrowed coronary arteries, Killip class, peak creatine kinase concentration, stent use, and medication use at discharge (aspirin, -blocker, calcium-channel antagonist, angiotensin-converting enzyme inhibitor, angiotensin-receptor blocker). The proportional hazards assumption was confirmed by the log (-log survival function). The influence of profile, interaction, and collinearity in the generalized linear model was examined using regression diagnostic analysis. Two-tailed p-values of less than 0.05 were considered to indicate a statistically significant difference.
Results
Patient Characteristics
For the study population as a whole (n=1,359), the mean age was 66.5±11.9 years, the male ratio was 74.8% (1,016 patients), 53.9% (733 patients) had hypertension, 35.6% (484 patients) had diabetes, 38.0% (516 patients) had dyslipidemia, 57.0% (775 patients) were current smokers, and 13.1% (178 patients) had a previous MI [48.6% (661 patients) had an anterior MI], 84.6% (1,150 patients) were Killip class I on presentation and 59.2% (805 patients) had single-vessel disease. The baseline serum creatinine concentration for the 1,359 patients was not normally distributed. The median baseline concentration was 0.9 mg/dl (interquartile range 0.7-1.1). A total of 216 patients (15.9%) were included in the elevated creatinine (≥1.2 mg/dl) group. Baseline characteristics of the patients with elevated and normal serum creatinine concentrations are shown in Table 1 .
Patients with elevated serum creatinine concentration were older, more often male, more likely to have systemic hypertension, previous MI, multivessel disease and to show symptoms of congestive heart failure on presentation. There were no statistical differences between the 2 groups in the time from onset to admission, elapsed time, and ratio of stent use. Medication use at discharge is shown in Table 2 .
There was no statistical difference in the use of nitrates, -blockers, calcium-channel antagonists and statins between the 2 groups, although patients in the elevated serum creatinine group were less likely to be treated with aspirin (89.1% vs 94.2%; p=0.021) and angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers (50.6% vs 71.3%; p=0.0001).
Clinical Outcomes and Predictors of Survival
The median follow-up period was 39 [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] months and follow-up rate was 97.5%. The Kaplan-Meier curve estimated that long-term mortality was higher in the elevated serum creatinine group (Fig 1) . In addition, an elevated serum creatinine concentration in study patients who survived hospitalization (n=1,272) also had an unfavorable long-term prognosis (Fig 2) .
Parameters explaining impaired renal function were analyzed by a multivariate Cox proportional hazards model. Elevated serum creatinine concentration was an independent predictor of a higher rate of long-term mortality in AMI patients undergoing successful PCI (Table 3) . Age (HR =1.06, 95% confidence interval [CI]: 1.04-1.07), Killip class (HR = 2.03, 95% CI: 1.80-2.29) and number of narrowed coronary arteries (HR =1.27, 95% CI: 1.05-1.54) were also independent predictors of higher long-term mortality. Use of aspirin (HR =0.48, 95% CI: 0.28-0.81) and angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers (HR = 0.61, 95% CI: 0.42-0.89) at discharge were independent predictors of lower long-term mortality.
The number of both cardiac and non-cardiac causes of deaths was higher in the elevated serum creatinine group and of these, cardiac death caused by heart failure was significantly increased (Table 4) .
Discussion
The principal finding of the present study is that an elevated serum creatinine concentration on admission independently increases the risk of long-term mortality in patients with AMI, even those who undergo successful primary PCI. The HIJAMI registry 15 is a Japanese large-scale prospective cohort of AMI and the mainstream arm for revascularization of the infarct-related artery was PCI. Therefore, we consider that our result reflects contemporary practice for AMI in the reperfusion era.
Our result extends previous retrospective analyses that have demonstrated that impaired renal function is associated with an increased risk of death in patients with AMI. 14,17, 18 Herzog et al examined long-term survival after AMI among patients on long-term dialysis and reported that only 41% of the patients survived for 1 year and 27% for 2 years. 4 The reason for the poor outcome in these patients was partially explained by an insufficient treatment strategy. Several investigators 5, 9 reported that (1) primary reperfusion therapy was performed less frequently in patients with any degree of renal insufficiency than in patients without renal insufficiency, despite a similar incidence of MI related to ST-segment elevation, and (2) patients with any degree of renal insufficiency were more likely to have contraindications to reperfusion therapy than those with normal renal function. Because our study was limited to patients with AMI successfully undergoing PCI, elevation of the serum creatinine concentration was conceivably independent of the revascularization strategy for AMI.
Moreover, these results are in agreement with previous studies of patients undergoing PCIl. Reinecke et al 19 indicated that long-term mortality increased with higher creatinine levels, with a significant difference starting at a level of 1.3 mg/dl and higher. They claimed that the decrease in renal function might represent a sensitive indicator of general microangiopathy induced by the presence of cardiovascular risk factors, particularly hypertension and diabetes. Pinkau et al 20 reported that patients with impaired renal function showed a rate of restenosis after PCI similar to that of patients with normal renal function, but there was a higher incidence of death or MI. They showed the existence of significant differences in baseline patient characteristics between patients with and without renal insufficiency and suggested that poor outcomes in the renal insufficiency patients could be explained by the multitude of comorbid conditions and worse preprocedural cardiac status.
In our study population, patients with elevated serum creatinine levels were older, more likely to present with symptoms of heart failure (Killip class ≥II), systemic hypertension, multivessel disease and have a history of MI than patients without renal decline. Nevertheless, the effect of an elevation of the serum creatinine concentration on long-term mortality was independent of these risk factors when evaluated in a multivariate model. Serum creatinine concentration is considered to correlate with oxidative stress, 21 endothelial dysfunction 22 and more progressive atherosclerosis. 23, 24 These biological abnormalities may also contribute to the excessive cardiovascular risk. Moreover, cardiac death from heart failure was significantly more common in the elevated serum creatinine group in the present study. Two factors may have contributed to these results. First, the higher level of serum creatinine also reflects clinical pathophysiological mechanisms such as low cardiac output, resulting in decreased renal blood flow, chronic volume overload and diastolic left ventricular function. Second, the elevated serum creatinine group had a greater prevalence of multivessel coronary disease and a history of MI. Although the precise mechanisms of the interaction between impaired renal function and coronary artery disease are not clarified, the serum creatinine concentration may be a marker for concomitant cardiovascular risk factors such as diabetes mellitus, systemic hypertension, and advanced age. In our sub-analyses, correlations among systemic hypertension, diabetes mellitus and serum creatinine level were observed.
Because the level of serum creatinine is of limited value in the early detection of renal insufficiency and is influenced by factors such as age, gender, race and lean muscle mass, there may be a claim that the serum creatinine level is an unreliable estimate of renal insufficiency. 25 In a recent report on renal insufficiency and AMI using creatinine clearance calculated by the Cockroft-Gault formula, the authors mentioned that nearly identical results were obtained using serum creatinine. 26 Because body weight was not available in our database, we decided to use the serum creatinine concentration in mg/dl as the measure of baseline renal insufficiency throughout the analysis.
Cystatin C, a cysteine protease inhibitor, is coming to the front as a better marker of glomerular filtration rate than creatinine. 27 Cystatin C is produced at a constant rate by all nucleated cells and freely filtered in the glomeruli, almost completely reabsorbed and catabolized by the proximal renal tubular cells. From their single center experience, Jernberg et al 28 reported that cystatin C had the best ability to discriminate between survivors and nonsurvivors in non-ST-elevation acute coronary syndrome patients. Shlipak et al 29 also described it as a stronger predictor of risk of death and cardiovascular events in elderly persons than creatinine in their community-based, longitudinal study. However, the measurement of cystatin C is still uncommon and relatively expensive, whereas measuring the serum creatinine concentration is very common, easy to assess (does not need an equation) and cheap. We believe that immediate risk stratification by the serum creatinine level for the management of AMI patients has significant meaning, especially in the setting of primary PCI, because the assessment of serum creatinine on presentation can induce the interventional cardiologist to pay attention to reducing the volume of contrast media that will be deleterious to the kidney. In routine clinical practice, together with our previous data that elucidated that renal insufficiency leads to poor in-hospital prognosis even in AMI patients undergoing successful PCI, 30 we need to immediately start making efforts to avoid worsening renal function after admission in order to improve the outcome of AMI patients.
In the present study, patients with elevated serum creatinine concentration were less likely to be discharged on aspirin and angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers, which have been demonstrated to reduce subsequent adverse coronary events and to prevent left ventricular remodeling. The reason why approximately 10% of patients with renal insufficiency were discharged without aspirin is thought to be that this population tends to have more contraindications for aspirin; for example, anemia, bleeding tendency and complex history of previous disease, compared with patients with normal renal function. This result corresponds to that of the report from Anavecker et al. 18 Their sub-analysis of the Valsartan in Acute Myocardial Infarction Trial (VALAINT) also indicated that the use of aspirin, -blockers and statins was lowest among patients with a reduced estimated glomerular filtration rate.
Several reports have elucidated that contrast-induced nephropathy is associated with poor prognosis after elective PCI. 31, 32 In addition, other reports have shown that contrast-induced nephropathy is an independent predictor of poor outcome in AMI patients. 14, 33 Marenzi et al reported that contrast-induced nephropathy occurred in 13% of AMI patients with a baseline creatinine clearance >60 ml/min, whereas it occurred in 40% of those with creatinine clearance <60 ml/min, and that AMI patients complicated with contrast-induced nephropathy had a significantly higher inhospital outcome rate (31%). 33 Although daily creatinine measurement was not routinely done in the patients in the HIJAMI registry, our sub-analysis from a single-center study population (n=132) similarly showed that 11.4% (15 patients) of them developed contrast-induced nephropathy and these patients had significantly higher in-hospital mortality and long-term (*median follow-up period was 39 [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] months) mortality rate (13.3% and 26.7%, respectively) compared with noncontrast-induced nephropathy patients (1.7% and 8.6%, respectively). 34 
Study Limitations
The major limitation of current study is that it is based on a data-driven post-hoc analysis of a cohort study. Second, the sample size is relatively small. Third, our database did not include information about the doses of contrast media and subsequent renal protection therapy.
Conclusion
To the best of our knowledge, this study shows the impact of an elevated serum creatinine concentration on the outcome for AMI patients who undergo successful primary PCI for the first time, using a multicenter, prospectively registered observational cohort. Because this is not a randomized controlled trial, but an observational cohort study, it was difficult to clarify the beneficial effect of reperfusion therapy in patients with AMI complicated with renal insufficiency. Nevertheless, the serum creatinine level of AMI patients on admission was an independent predictor of long-term mortality and we conclude that an elevation of the serum creatinine concentration is integrally related to survival after a variety of cardiac and noncardiac events. Further research into the clinical and biological mechanisms for this correlation and a large-scale, randomized controlled trial including patients with renal insufficiency are warranted.
